Drugs · acquisition-cost intelligence
Clindagel
CLINDAMYCIN· ingredient clindamycinAntibiotics· CLINDAMYCIN PHOSPHATE 10 mg/mL; CLINDAMYCIN PHOSPHATE 1 g/100mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$4.02
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other clindamycin products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Clindamycin Phosphate | $0.13710 | −$3.88 |
| Cleocin Pediatric | $0.14112 | −$3.88 |
| Cleocin Hydrochloride | $0.17586 | −$3.84 |
| Clindamycin HCL | $0.17586 | −$3.84 |
| Cleocin T | $0.18000 | −$3.84 |
| Clindacin P | $0.20298 | −$3.82 |
| Cleocin | $1.79 | −$2.23 |
| Clindacin | $2.31 | −$1.71 |
Medicare Part D coverage · CY2026
On 234 plan formularies · typical tier 3
Prior auth 21% · Step therapy 0% · Quantity limit 64% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.